Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
38°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
19
20
21
22
23
24
25
26
Next >
Analyst Ratings For Regeneron Pharmaceuticals
January 31, 2022
Tickers
REGN
Tags
BZI/AAR
REGN
Benzinga
From
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
Benzinga
PFE
LLY
From
Benzinga
CHMP Backs Sanofi-Regeneron's Dupixent For Asthma Patients Aged 6 - 11 Years With Type 2 Inflammation
January 31, 2022
Tickers
REGN
SNY
Tags
Market News
Benzinga
SNY
From
Benzinga
Market corrections are good buying opportunities, says Goldman Sachs — but only when this happens
January 31, 2022
Tickers
CTRA
LPX
MRNA
REGN
Tags
LPX
CTRA
SWKS
From
MarketWatch
A Deep Dive Into the Video Game Industry
January 29, 2022
Tickers
AAL
AAPL
AMZN
ATVI
Tags
ZNGA
AMZN
PG
From
Motley Fool
Can AbbVie Beat Pfizer in the Atopic Dermatitis Market?
January 29, 2022
Tickers
ABBV
PFE
REGN
SNY
Tags
REGN
PFE
Recent Press Releases
From
Motley Fool
Regeneron, Sanofi Withdraw FDA Application For Libtayo's Expanded Use
January 28, 2022
Tickers
REGN
SNY
Tags
General
News
SNY
From
Benzinga
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
January 28, 2022
Tickers
ALXO
BGNE
BIIB
IBB
Tags
BGNE
NRIX
IBB
From
Benzinga
J&J exec says biotechs aren’t ‘necessarily on sale’ even after a challenging 2021
January 27, 2022
Tickers
BNTX
DRG
IBB
JNJ
Tags
JNJ
IBB
XBI
From
MarketWatch
Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
January 25, 2022
Tickers
BNTX
GSK
LLY
MRK
Tags
GSK
UK:GSK
BNTX
From
MarketWatch
A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Earnings, Fed Meeting
January 25, 2022
Tickers
AXP
BRO
IBM
JNJ
Tags
Pre/Market Outlook
News
Earnings
From
Benzinga
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
January 24, 2022
Tickers
GILD
LLY
MRK
PFE
Tags
General
News
Pandemic
From
Benzinga
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
January 24, 2022
Tickers
AZN
LLY
MRK
PFE
Tags
AZN
Coronavirus
Health Care
From
Benzinga
Second Dupixent Phase 3 Trial Confirms Significant Improvements In Inflammatory Skin Disease
January 19, 2022
Tickers
REGN
SNY
Tags
SNY
Briefs
News
From
Benzinga
The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data
January 19, 2022
Tickers
ADMA
ASLN
BGNE
CRDF
Tags
FDA
Small Cap
Biotech
From
Benzinga
Regeneron Announces FDA Accepts For Review Libtayo In Combination With Chemotherapy For First-Line Treatment Of Advanced NSCLC
January 19, 2022
Tickers
REGN
Tags
REGN
Benzinga
FDA
From
Benzinga
2 Top Biotech Stocks to Buy and Hold for 10 Years
January 17, 2022
Tickers
MRK
MRNA
PFE
REGN
Tags
PFE
MRK
Market News
From
Motley Fool
3 Top Biotech Stocks to Buy Right Now
January 15, 2022
Tickers
GSK
NVS
REGN
SNY
Tags
GSK
SNY
NVS
From
Motley Fool
WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge
January 14, 2022
Tickers
GSK
LLY
REGN
VIR
Tags
Government
COVID/19 Coronavirus
General
From
Benzinga
Connect Biopharma's Latest Dermatitis Drug Update Fails to Pump Up Shares
January 13, 2022
Tickers
CNTB
IMAB
LLY
PFE
Tags
Market News
IMAB
LLY
From
Benzinga
1 Key Ratio All Investors Should Be Looking at When Buying Growth Stocks in 2022
January 13, 2022
Tickers
ARKK
FUBO
REGN
TSLA
Tags
TSLA
Market News
ARKK
From
Motley Fool
Why JPMorgan Is Among Rob Sechan's Top Picks For 2022
January 10, 2022
Tickers
EOG
JPM
REGN
Tags
Market News
EOG
Long Ideas
From
Benzinga
Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays
January 05, 2022
Tickers
PFE
REGN
Tags
PFE
Benzinga
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
January 05, 2022
Tickers
ACAD
ADBE
ADTH
AEL
Tags
INTC
MGY
OXY
From
Benzinga
3 Healthcare Stocks That Could Rocket Higher in 2022
January 04, 2022
Tickers
ALGN
NTLA
REGN
SAVA
Tags
REGN
Recent Press Releases
SAVA
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 3, 2022
January 03, 2022
Tickers
ACC
ADTH
ALNY
AVB
Tags
Downgrades
ALNY
CHTR
From
Benzinga
Better Buy: CRISPR vs. Intellia
January 03, 2022
Tickers
BLUE
CRSP
NTLA
REGN
Tags
REGN
CRSP
Recent Press Releases
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
December 31, 2021
Tickers
ALNY
ETON
IBB
NVS
Tags
News
SNY
NVS
From
Benzinga
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
December 29, 2021
Tickers
CYDY
GILD
GSK
LLY
Tags
Opinion
CYDY
VIR
From
Benzinga
AstraZeneca's COVID-19 Antibody Effective Against Omicron Variant
December 16, 2021
Tickers
AZN
AZNCF
REGN
Tags
Briefs
News
Biotech
From
Benzinga
< Previous
1
2
...
19
20
21
22
23
24
25
26
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.